Multi-centered Liraglutide add-on SU or diet alone study in West-Tokyo area

Multi-centered Liraglutide add-on SU or diet alone study in West-Tokyo area - Liraglutide study adding-on SU or diet alone

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003560

Enrollment

Registered

2010-10-15

Start date

2010-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type2 diabetes

Interventions

Injection of Liraglutide, withdrawal of Liraglutide after achievement of glycemic control HbA1c&lt

6.1%.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: HbA1c more than 6.5%, Type 2 diabetes, diet and exercise alone or prescribed surfonyl urea, 20 year-old or older, capable of injecting by themselves.

Exclusion criteria

Exclusion criteria: Serious hypoglycemia, serious diabetic retinopathy, serious heart failure, with malignant tumor, pregnant, prescribed TZD or glinide.

Design outcomes

Primary

Measure	Time frame
HbA1c	—

Secondary

Measure	Time frame
Body weight, achievement of the goal, pancreas function, medications, AE, withdrawal rate, blood pressure, waist circumference, cholesterols, QOL	—

Countries

Japan

Contacts

Public ContactTakaichi Miyakawa, Yuko Watanabe, Hitomi Fujii

Tama-center Mirai Clinic Internal Medicine

irb-mirai@tama-mirai.com042-316-8570

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026